Cited by 83Attention Deficit Hyperactivity DisorderMedication Adherence and CompliancePharmaceutical studies and practices

Compliance with pharmacological and cognitive treatments for attention deficit disorder

BROWN, RONALD T., BORDEN, KATHI A., WYNNE, MARTHA ELLEN, SPUNT, AVERY L., CLINGERMAN, STEPHEN R.·1987·Journal of the American Academy of Child & Adolescent Psychiatry

Integrity signals

Registry

Crossref · 10.1097/00004583-198707000-00010

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Our data suggest that new drug delivery systems such as SLI381 (Adderall XR) represent a successful strategy to extend the benefits of psychostimulant treatment of ADHD without incurring added side effects, thereby avoiding some compliance issues raised by shorter-acting stimulant preparations.

    “Our data suggest new drug delivery systems such as SLI381 (Adderall XR) represent a successful strategy to extend the benefits of psychostimulant treatment of ADHD without incurring added side effects, thereby avoiding some of the compliance issues raised by shorter-acting stimulant preparations (Brown et al., 1987;Firestone, 1982;Kauffman et al., 1981).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
BROWN, R. T., BORDEN, K. A., WYNNE, M. E., SPUNT, A. L., & CLINGERMAN, S. R.
Affiliations
Pepperdine University (US)
Corresponding author
BROWN, RONALD T.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
1987-07
Volume
26
Issue
4
Pages
521-526
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2045411458
Cited by
83
References
25
Citations by year
2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 1 · 2014: 3 · 2013: 1 · 2012: 3
FWCI
2.70
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
U. S. Public Health Service (MH 37-628)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
attention deficit disorder, medication adherence, methylphenidate, cognitive therapy, psychotherapy adherence, children, socioeconomic status, pill count, treatment completion
MeSH terms
Adolescent, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Child, Cognition, Female, Humans, Male, Methylphenidate, Patient Compliance, Social Class

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review